author-photo

Barbara Scappini

University of Florence

49

Papers

486

Citations

Citation Trend

Filter By

Papers (36) Sort By

Journal Conference Others

Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience

2021 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (2)
CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools

2021 Targeted Oncology
Show All
- Source
- Cite
- Save
Citations (0)
AML-188: Venetoclax with Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Multilineage Dysplasia as Assessed by Immunophenotype in Acute Myeloid Leukemia: A Prognostic Tool in a Genetically Undefined Category.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Successful use of Caplacizumab in a case of refractory acquired thrombotic thrombocytopenic purpura following subacute thyroiditis

2020 Transfusion and Apheresis Science
Show All
- Source
- Cite
- Save
Citations (0)
A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-center Study of FLT3 mutated AML patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitors Administration in the Real-Life Clinical Practice

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm

2020 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (6)
THIRD GENERATION SEQUENCING OF NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA: IMPLICATIONS FOR PROGNOSIS

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (1)
REAL‐WORD EXPERIENCE WITH DECITABINE AS A FIRST‐LINE TREATMENT IN 306 ELDERLY ACUTE MYELOID LEUKAEMIA PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY.

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (11)